Polypharmacy in elderly: a cautious trail to tread.

Area of Science:

• Geriatric Medicine
• Clinical Pharmacology
• Public Health

Background:

• Polypharmacy is a growing concern in elderly healthcare globally.
• In older adults, polypharmacy is linked to increased adverse drug reactions (ADRs) and drug-drug interactions, leading to significant morbidity.
• Geriatrics is an emerging specialty in South Asia, particularly Pakistan, with unique drivers of polypharmacy.

Purpose of the Study:

• To review the literature on polypharmacy in the elderly.
• To evaluate guidelines for interventions aimed at reducing inappropriate drug prescribing in older adults.
• To highlight common drug classes associated with adverse events in the elderly.

Main Methods:

• Extensive literature review using keywords 'polypharmacy' and 'elderly'.
• Detailed review of the updated Beers Criteria for inappropriate medication use in older adults.
• Analysis of relevant articles on polypharmacy and intervention guidelines.

Main Results:

• Commonly prescribed medications (psychotropics, cardiovascular drugs, NSAIDs, oral hypoglycemics) pose risks in the elderly.
• Evidence-based non-pharmacological interventions can be beneficial in selected cases.
• A systematic approach to prescribing, considering aging physiology and pharmacology, is crucial.

Conclusions:

• Polypharmacy significantly impacts the quality of life and morbidity in the elderly.
• Minimizing iatrogenic complications requires a foundational understanding of geriatric physiology and pharmacology.
• Appropriate interventions and prescribing practices are essential for safer medication management in older patients.